Understanding How an Antiarrhythmic Drug Helps Control Irregular Heartbeats

ANTI ARRHYTHMIC DRUGS

Introduction

Cardiac arrhythmias are common medical conditions that nurses encounter in emergency, ICU and cardiac units. Understanding antiarrhythmic drugs is important not only for exam but also to improve patient care and clinical decision making.
In this blog we will explain arrhythmas,  anti-arrhythmic drugs, their mechanism and classification with example

Definition of Arrhythmia

Arrhythmia is a condition in which the electrical activity of the heart and the rhythm of the heartbeat become abnormal. This means the heart will beat either too fast, too slow, or irregularly.

arrhythmia

Definition of Anti-Arrhythmia / Antiarrhythmic-Drugs

An antiarrhythmic drug is a medication used to prevent, treat, or control abnormal heart rhythms (arrhythmias) by changing the electrical activity of the heart.

Mechanism of Arrhythmia (How does arrhythmia occur?)

Anti arrhythmic drugs work by controlling the electrical activity of the heart. Arrhythmias happen when electrical impulses move too fast, too slow, or irregularly. These drugs help restore normal rhythm by affecting ion channels, refractory period, and conduction speed.

The heart’s electrical cycle (action potential) has 5 phases:

  • Phase 0 – Rapid depolarization (Na⁺ influx)
  • Phase 1 – Early repolarization
  • Phase 2 – Plateau (Ca²⁺ influx)
  • Phase 3 – Repolarization (K⁺ efflux)
  • Phase 4 – Resting phase
Anti arrhythmic drugs act on different phases:

1.Class I – Sodium Channel Blockers (Phase 0 Action)

Mechanism:

These drugs block fast Na⁺ channels, slow depolarization, and decrease conduction velocity.

They reduce the excitability of cardiac cells.

 

Subtypes:

Class IA – Moderate Na⁺ block

Prolong action potential

Examples: Quinidine, Procainamide, Disopyramide

Class IB – Weak Na⁺ block

Shorten action potential

Examples: Lidocaine, Mexiletine

Class IC – Strong Na⁺ block

Markedly slow conduction

Examples: Flecainide, Propafenone

2.Class II – Beta Blockers (Phase 4 Action)

Mechanism:
They block beta-adrenergic receptors → slow SA and AV node conduction.
They decrease heart rate and reduce automaticity.

Examples: Metoprolol, Propranolol, Atenolol

Used for: SVT, AF rate control, palpitations

3.Class III – Potassium Channel Blockers (Phase 3 Action)

Mechanism:
Block K⁺ channels, prolong repolarization and action potential duration.
Increase refractory period → prevents re-entry arrhythmia.

Examples: Amiodarone, Sotalol, Dofetilide

Used for: Atrial fibrillation, ventricular tachycardia

4.Class IV – Calcium Channel Blockers (Phase 2 & AV Node)

Mechanism:
Block L-type Ca²⁺ channels → slow AV node conduction.
Reduce contractility and heart rate.

Examples: Verapamil, Diltiazem

Used for: SVT, atrial flutter, AF rate control

5.Class V – Miscellaneous Mechanisms

These drugs work through unique mechanisms.

Adenosine

  • Slows AV node conduction
  • “Resets” the heart in SVT

Digoxin

  • Increases vagal tone
  • Slows AV node rate (useful in AF)

Magnesium sulfate

  • Stabilizes heart cell membranes
  • Used in torsades de pointes
classifcation of antiarrythmic drugs

12 May International NursesDay 2024